Partnerships are key to unlocking China's personalised medicine potential
This article was originally published in Clinica
Executive Summary
China, with its huge healthcare market and strong economic growth, presents an attractive prospect for diagnostics firms. The Chinese government has backed the concept of personalised medicine, and yet the industry is in a fledgling state with no clear domestic or foreign leaders. Kate Carlisle of Cambridge Consultants reports on the benefits and challenges in commercialising companion diagnostics in China